{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:11:11Z","timestamp":1791976271453,"version":"4.4.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Carcinosarcoma is a rare and aggressive malignant neoplasm that predominantly affects elderly postmenopausal women and can involve various gynecologic organs. It is characterized by the presence of both malignant epithelial and sarcomatous components. While most uterine carcinosarcomas (UCS) are homologous (sarcomatous component consisting of elements native to the uterus), heterologous components are less common and may vary in composition. Rare heterologous elements can include lipomatous (liposarcoma) or osseous elements (osteosarcoma). We present an unusual case of a 31-year-old female with UCS exhibiting osseous heterologous elements. The patient underwent successful surgical resection and remains in remission during follow-up. This case is notable for its rarity, as highlighted by the uncommon age of the patient and the presence of rare heterologous elements in the UCS. Furthermore, it provides new insights into the diverse presentations of UCS and underscores the importance of comprehensive evaluation in understanding its clinical manifestations.<\/jats:p>","DOI":"10.3389\/fonc.2025.1505504","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T05:10:48Z","timestamp":1739509848000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Uterine carcinosarcoma with heterologous osseous elements: a case report of an extremely rare clinical occurrence with literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Hiba A.","family":"Al Dallal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor H.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody L.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshi","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer Z.","family":"Al-Quran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet Kaur","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10283","article-title":"Carcinosarcoma of the uterus: A study from the surveillance epidemiology and end result (Seer) database","volume":"12","author":"Nama","year":"2020","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-077974","article-title":"Epidemiology, site-specific characteristics and survival of carcinosarcoma: A retrospective study based on seer database","volume":"13","author":"Tang","year":"2023","journal-title":"BMJ Open"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.03.041","article-title":"Uterine carcinosarcoma: A review of the literature","volume":"137","author":"Cantrell","year":"2015","journal-title":"Gynecol Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.6004\/jnccn.2009.0037","article-title":"Carcinosarcomas (Malignant mixed m\u00fcllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics","volume":"7","author":"Kernochan","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.14670\/hh-30.673","article-title":"Carcinosarcomas: tumors in transition","volume":"30","author":"Somarelli","year":"2015","journal-title":"Histol Histopathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2017.74.9523","article-title":"Carcinosarcomas and related cancers: tumors caught in the act of epithelial-mesenchymal transition","volume":"36","author":"Pang","year":"2018","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11070964","article-title":"Molecular basis of tumor heterogeneity in endometrial carcinosarcoma","volume":"11","author":"Leskela","year":"2019","journal-title":"Cancers"},{"key":"B8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ygyno.2020.10.043","article-title":"Uterine carcinosarcoma: contemporary clinical summary, molecular updates, and future research opportunity","volume":"160","author":"Matsuzaki","year":"2021","journal-title":"Gynecol Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.88","article-title":"Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component","volume":"24","author":"de Jong","year":"2011","journal-title":"Mod Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/pgp.0000000000000346","article-title":"Uterine carcinosarcomas: clinical, histopathologic and immunohistochemical characteristics","volume":"36","author":"Chen","year":"2017","journal-title":"Int J Gynecological Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.02.010","article-title":"Integrated molecular characterization of uterine carcinosarcoma","volume":"31","author":"Cherniack","year":"2017","journal-title":"Cancer Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/pgp.0000000000000736","article-title":"Folate receptor alpha is preferentially expressed in the carcinoma component of endometrial carcinosarcomas: A potential target for adjuvant therapy","volume":"40","author":"Hanley","year":"2021","journal-title":"Int J Gynecological Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2016-0518-RA","article-title":"Application of immunohistochemistry in undifferentiated neoplasms: A practical approach","volume":"141","author":"Kandukuri","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/pgp.0000000000000301","article-title":"Satb2 expression is sensitive but not specific for osteosarcomatous components of gynecologic tract carcinosarcomas: A clinicopathologic study of 60 cases","volume":"36","author":"Sangoi","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/his.12911","article-title":"Special at-Rich Sequence-Binding Protein 2 (Satb2) Expression Is Sensitive but May Not Be Specific for Osteosarcoma as Compared with Other High-Grade Primary Bone Sarcomas","volume":"69","author":"Davis","year":"2016","journal-title":"Histopathology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e31829ff239","article-title":"Immunohistochemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas","volume":"33","author":"Hoang","year":"2014","journal-title":"Int J Gynecological Pathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0000000000001434","article-title":"Mismatch repair deficiency in uterine carcinosarcoma: A multi-institution retrospective review","volume":"44","author":"Jenkins","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800654","article-title":"DNA mismatch repair and tp53 defects are early events in uterine carcinosarcoma tumorigenesis","volume":"19","author":"Taylor","year":"2006","journal-title":"Modern Pathol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/pgp.0000000000000662","article-title":"Immunohistochemical markers with potential diagnostic, prognostic, and therapeutic significance in uterine carcinosarcoma: A clinicopathologic study of 43 cases","volume":"40","author":"Jones","year":"2021","journal-title":"Int J Gynecological Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/pgp.0000000000000752","article-title":"Pd-L1 and mismatch repair status in uterine carcinosarcomas","volume":"40","author":"Jenkins","year":"2021","journal-title":"Int J Gynecological Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw161","article-title":"Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma","volume":"27","author":"Matsuo","year":"2016","journal-title":"Ann Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2023.34.e73","article-title":"Prognostic significance of heterologous component in carcinosarcoma of the gynecologic organs: A systematic review and meta-analysis","volume":"34","author":"Kim","year":"2023","journal-title":"J Gynecol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2018.05.017","article-title":"Characterizing sarcoma dominance pattern in uterine carcinosarcoma: homologous versus heterologous element","volume":"27","author":"Matsuo","year":"2018","journal-title":"Surg Oncol"},{"key":"B24","unstructured":"Abu-Rustum\n              N\n            \n            \n              Yashar\n              C\n            \n            \n              Arend\n              R\n            \n            \n              Barber\n              E\n            \n            \n              Bradley\n              K\n            \n            \n              Brooks\n              R\n            \n          \n          National Comprehensive Cancer Network - Clinical Practice Guidelines in Oncology (Nccn Guidelines\n          Uterine Neoplasms, Version 3\n          \n          2024"},{"key":"B25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ygyno.2017.02.001","article-title":"Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma","volume":"145","author":"Matsuo","year":"2017","journal-title":"Gynecologic Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omad157","article-title":"Uterine carcinosarcoma with heterologous mesenchymal element: A case report of a rare and aggressive tumor","volume":"2024","author":"Asfer","year":"2024","journal-title":"Oxf Med Case Rep"},{"key":"B27","article-title":"Uterine carcinosarcoma presenting as metastatic osteosarcoma in the lung: A case report and literature review","volume":"53","author":"Amin","year":"2023","journal-title":"Ann Clin Lab Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.12892\/ejgo3991.2018","article-title":"Osteosarcoma appearing in the uterus as Malignant mixed m\u00fcllerian tumor","volume":"39","author":"Jin","year":"2018","journal-title":"Eur J Gynaecological Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.tjog.2012.01.018","article-title":"Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: A case report","volume":"51","author":"Kahraman","year":"2012","journal-title":"Taiwanese J Obstetrics Gynecology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(93)90291-N","article-title":"Carcinosarcoma (Malignant mixed m\u00fcllerian (Mesodermal) tumor) of the female genital tract: immunohistochemical and ultrastructural analysis of 28 cases","volume":"24","author":"de Brito","year":"1993","journal-title":"Hum Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800101)45:1<188::AID-CNCR2820450129>3.0.CO;2-Y","article-title":"Malignant mullerian mixed tumors of the uterus a study of 21 cases","volume":"45","author":"King","year":"1980","journal-title":"Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1505504\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T05:10:53Z","timestamp":1739509853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1505504\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":31,"alternative-id":["10.3389\/fonc.2025.1505504"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1505504","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"article-number":"1505504"}}